XML 142 R119.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation - Schedule of Activities for Stock Options (Details)
¥ in Thousands, shares in Thousands
12 Months Ended
Dec. 31, 2021
$ / shares
shares
Dec. 31, 2020
CNY (¥)
$ / shares
shares
Dec. 31, 2019
CNY (¥)
$ / shares
shares
Dec. 31, 2018
CNY (¥)
$ / shares
shares
Dec. 31, 2017
$ / shares
Dec. 31, 2021
CNY (¥)
shares
Options Outstanding            
Granted (in shares) 13,736 3,005 10,849      
Cancelled/forfeited (in shares) (5,201) (2,539) (1,903)      
Weighted Average Exercise Price            
Exercise Price | $ / shares $ 0.0001          
Employees, Directors and Non-employee Directors            
Options Outstanding            
Balance at the beginning of the period (in shares) 13,660 16,241 20,142      
Granted (in shares) 13,489 2,829 5,091      
Exercised (in shares) (2,426) (3,140) (7,798)      
Cancelled/forfeited (in shares) (4,594) (2,270) (1,194)      
Balance at the end of the period (in shares) 20,129 13,660 16,241 20,142    
Vested and expected to vest at the end of the period (in shares)           18,867
Exercisable at the end of the period (in shares)           4,447
Weighted Average Exercise Price            
Balance at the beginning of the period (in dollars per share) | $ / shares $ 1.7569 $ 1.7386 $ 1.5164      
Exercise Price | $ / shares 0.5000 0.5000 0.5000   $ 0.0001  
Exercised (in dollars per share) | $ / shares 0.4529 0.2399 0.2548      
Cancelled/forfeited (in dollars per share) | $ / shares 3.2215 2.1589 2.3996      
Balance at the end of the period (in dollars per share) | $ / shares 0.7227 $ 1.7569 $ 1.7386 $ 1.5164    
Vested and expected to vest at the end of the period (in dollars per share) | $ / shares 0.7355          
Exercisable at the end of the period (in dollars per share) | $ / shares $ 1.2408          
Weighted Average Remaining Contractual Life and Aggregate Intrinsic Value            
Weighted average remaining contractual life (in years) 8 years 5 months 4 days 7 years 10 months 13 days 8 years 2 months 19 days 7 years 11 months 12 days    
Vested and expected to vest at the end of the period, weighted average remaining contractual life 8 years 5 months 1 day          
Exercisable at the end of the period, weighted average remaining contractual life 6 years 6 months 10 days          
Aggregate Intrinsic Value | ¥   $ 189,072 $ 589,871 $ 353,559   ¥ 155,018
Vested and expected to vest at the end of the period, Aggregate intrinsic value | ¥           143,684
Exercisable at the end of the period, Aggregate intrinsic value | ¥           ¥ 19,540
Non-employees            
Options Outstanding            
Balance at the beginning of the period (in shares) 410 410 500      
Exercised (in shares) (160)   (90)      
Balance at the end of the period (in shares) 250 410 410 500    
Vested and expected to vest at the end of the period (in shares)           250
Exercisable at the end of the period (in shares)           250
Weighted Average Exercise Price            
Balance at the beginning of the period (in dollars per share) | $ / shares $ 0.0001 $ 0.0001 $ 0.0001      
Exercised (in dollars per share) | $ / shares 0.0001   0.0001      
Balance at the end of the period (in dollars per share) | $ / shares   $ 0.0001 $ 0.0001 $ 0.0001    
Vested and expected to vest at the end of the period (in dollars per share) | $ / shares 0.0001          
Exercisable at the end of the period (in dollars per share) | $ / shares $ 0.0001          
Weighted Average Remaining Contractual Life and Aggregate Intrinsic Value            
Weighted average remaining contractual life (in years) 5 years 6 months 29 days 6 years 6 months 29 days 7 years 6 months 29 days 8 years 6 months 29 days    
Vested and expected to vest at the end of the period, weighted average remaining contractual life 5 years 6 months 29 days          
Exercisable at the end of the period, weighted average remaining contractual life 5 years 6 months 29 days          
Aggregate Intrinsic Value | ¥   $ 8,962 $ 19,864 $ 12,439   ¥ 3,076
Vested and expected to vest at the end of the period, Aggregate intrinsic value | ¥           3,076
Exercisable at the end of the period, Aggregate intrinsic value | ¥           ¥ 3,076